Valuation Novo Nordisk A/S

Stocks

Market Closed - Nasdaq Copenhagen Other stock markets 11:20:00 2026-07-21 EDT			5-day change	1st Jan Change
324.05 ^DKK	-1.20%		+1.36%	-0.37%

07-21	Healthcare Shares Rise -- Healthcare Roundup	DJ
07-21	What we know of weight-loss drugs' pricing, availability as Novo sues Lilly	RE

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	1,674,992	2,118,803	3,112,331	2,772,285	1,445,242	1,433,226	-	-
Change	-	26.5%	46.89%	-10.93%	-47.87%	-0.83%	-	-
Enterprise Value (EV) ¹	1,684,152	2,121,013	3,109,107	2,848,764	1,549,238	1,560,825	1,559,667	1,544,474
Change	-	25.94%	46.59%	-8.37%	-45.62%	0.75%	-0.07%	-0.97%
P/E	35.4x	38.4x	37.5x	27.6x	14.1x	14.3x	15.3x	14.1x
PBR	24x	25.6x	29.4x	19.3x	-	6.31x	5.61x	5.01x
PEG	-	2.2x	0.7x	1.3x	7.98x	-9.31x	-2.28x	1.6x
Capitalization / Revenue	11.9x	12x	13.4x	9.55x	4.68x	4.88x	4.76x	4.48x
EV / Revenue	12x	12x	13.4x	9.81x	5.01x	5.31x	5.18x	4.83x
EV / EBITDA	26x	25.8x	27.8x	19.3x	10.4x	10.9x	10.9x	10.1x
EV / EBIT	28.7x	28.4x	30.3x	22.2x	12.1x	12.9x	12.8x	11.9x
EV / FCF	57.4x	37x	45.5x	38.6x	26.3x	33.7x	21.9x	19.2x
FCF Yield	1.74%	2.7%	2.2%	2.59%	3.81%	2.96%	4.56%	5.21%
Dividend per Share ²	5.2	6.2	9.4	11.4	11.7	11.35	11.07	12.18
Rate of return	1.41%	1.32%	1.35%	1.83%	3.6%	3.5%	3.42%	3.76%
EPS ²	10.37	12.22	18.62	22.63	23.03	22.68	21.15	23.02
Distribution rate	50.1%	50.7%	50.5%	50.4%	50.8%	50%	52.3%	52.9%
Net sales ¹	140,800	176,954	232,261	290,403	309,064	293,810	301,181	320,040
EBITDA ¹	64,669	82,171	111,987	147,446	149,640	142,593	142,633	152,970
EBIT ¹	58,644	74,809	102,574	128,339	127,658	121,207	121,623	130,145
Net income ¹	47,757	55,525	83,683	100,988	102,434	99,283	93,902	100,520
Net Debt ¹	9,160	2,210	-3,224	76,479	103,996	127,599	126,441	111,248
Reference price ²	367.50	469.00	698.10	624.20	325.25	324.05	324.05	324.05
Nbr of stocks (in thousands)	4,557,801	4,517,704	4,458,288	4,441,340	4,443,479	4,422,856	-	-
Announcement Date	2/2/22	2/1/23	1/31/24	2/5/25	2/3/26	-	-	-

¹DKK in Million²DKK

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
NOVO NORDISK A/S	14.46x	5.38x	11.08x	3.46%	222B
ELI LILLY AND COMPANY	34.09x	12.2x	25.51x	0.59%	1,023B
JOHNSON & JOHNSON	26.74x	6.1x	16.7x	2.16%	599B
ABBVIE INC.	33.01x	7.5x	15.37x	2.71%	448B
ROCHE HOLDING AG	17.72x	4.39x	10.82x	3.02%	326B
NOVARTIS AG	21.23x	5.45x	13.2x	2.93%	278B
ASTRAZENECA PLC	20.75x	4.38x	12.12x	2.01%	258B
AMGEN INC.	23.89x	6.31x	11.13x	2.77%	197B
GILEAD SCIENCES, INC.	-47.99x	5.74x	31.73x	2.44%	165B
PFIZER INC.	12.57x	3.08x	7.79x	6.97%	141B
Average	15.65x	6.05x	15.55x	2.91%	365.61B
Weighted average by Cap.	23.09x	7.49x	17.58x	2.22%